.OS Therapies will specify on the NYSE American sell substitution today by means of a $6.4 thousand ...
.ALX Oncology's period 2 gastric cancer cells reaction fee has actually weakened. After observing it...
.One More of Ionis Pharmaceuticals' crucial midphase readouts has actually disappointed desires, cui...
.While Biogen's pharma peers are actually seeking for late-stage properties along with little threat...
.Instil Biography has been a biotech looking for a pipe after it ditched its lead possessions over t...
.Biogen has actually handed back rights to an early Alzheimer's condition plan to Denali Therapies, ...
.Invite to today's Chutes & Ladders, our summary of considerable leadership hirings, shootings as...
.Vertex's try to treat an uncommon genetic condition has reached another problem. The biotech tossed...
.Vir Biotechnology's second-quarter earnings file wasn't short of huge news. The business invited a ...
.Galapagos has paused registration in a test of a BCMA-directed CAR-T tissue therapy, pumping the br...